Get the Stockscreener App
1.36
8.11%
-0.12
After Hours:
1.36
Ernexa Therapeutics Inc Stock (ERNA) Forecast
The Ernexa Therapeutics Inc (ERNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1199, representing a -91.18% decrease from the current price of $1.36. The highest analyst price target is $0.042, and the lowest is $0.1979.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ERNA Price Target
Average 0.768
(-43.53% Downside)
Is Ernexa Therapeutics Inc (ERNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.46 | Neutral |
| STOCH(9,6) | 71.02 | Neutral |
| STOCHRSI(14) | 69.37 | Neutral |
| MACD(12,26) | -0.0264 | Buy |
| ADX(14) | 24.35 | Neutral |
| William %R | -35.00 | Neutral |
| CCI(14) | 52.29 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.296
Buy
|
1.3417
Buy
|
| MA20 |
1.343
Buy
|
1.3594
Buy
|
| MA50 |
1.3962
Sell
|
1.4022
Sell
|
| MA100 |
1.4215
Sell
|
1.6954
Sell
|
| MA200 |
2.1881
Sell
|
3.6728
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ERNA could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ERNA, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.46 indicates that ERNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.02 indicates that ERNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.37 indicates that ERNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.35 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 52.29 indicates that ERNA is still overbought but not to an extreme extent.
Long-term ERNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ernexa Therapeutics Inc financial reports and earnings history, Ernexa Therapeutics Inc (ERNA) stock could reach $4.4735 by 2030, $18.45 by 2040 and $20.62 by 2050. See the projected annual prices until 2050 of the Ernexa Therapeutics Inc stock below:
- Ernexa Therapeutics Inc (ERNA) is expected to reach an average price of $11.36 in 2035, with a high prediction of $11.80 and a low estimate of $11.49. This indicates an $734.98% rise from the last recorded price of $1.36.
- Ernexa Therapeutics Inc (ERNA) stock is projected to chart a bullish course in 2040, with an average price target of $18.20, representing an $1,238% surge from its current level. The forecast ranges from a conservative $18.42 to a sky-high $18.45.
- Our analysts predict Ernexa Therapeutics Inc (ERNA) to jump 851.06% by 2045, soaring from $13.13 to an average price of $12.93, potentially reaching $13.67. While $13.13 is the low estimate, the potential upside is significant.
- Ernexa Therapeutics Inc (ERNA) stock is expected to climb by 2050, reaching an average of $20.21, a $1,386% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.62 and $20.52, respectively, highlighting the market's uncertainty.
Ernexa Therapeutics Inc Stock (ERNA) Year by Year Forecast
Ernexa Therapeutics Inc Stock (ERNA) Price Forecast for 2026
The predicted value for Ernexa Therapeutics Inc (ERNA) in 2026 is set at an average of $0.768. Estimates vary from a peak of $1.535 to a trough of $0.00106, indicating an -43.53% surge from the present price of $1.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.00566 | $0.1979 | $0.042 | -99.58% |
| February, 2026 | $0.3393 | $0.3032 | $0.2676 | -75.05% |
| March, 2026 | $0.6307 | $0.4746 | $0.2607 | -53.62% |
| April, 2026 | $1.1875 | $0.5713 | $0.7175 | -12.68% |
| May, 2026 | $1.3289 | $1.3029 | $1.2439 | -2.28% |
| June, 2026 | $0.8049 | $1.2804 | $1.3397 | -40.82% |
| July, 2026 | $0.6272 | $0.4318 | $0.3857 | -53.89% |
| August, 2026 | $0.5036 | $0.4932 | $0.6025 | -62.97% |
| September, 2026 | $0.1554 | $0.3629 | $0.37 | -88.58% |
| October, 2026 | $0.4832 | $0.0639 | $0.6039 | -64.47% |
| November, 2026 | $0.0283 | $0.2071 | $0.6078 | -97.92% |
| December, 2026 | $1.6561 | $0.00106 | $1.535 | +21.77% |
Ernexa Therapeutics Inc Stock (ERNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ernexa Therapeutics Inc (ERNA) is $2.0536, with a high forecast of $2.5445 and a low forecast of $1.5627. This indicates an +51.00% increase from the last price of $1.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0282 | $1.799 | $1.5572 | +49.13% |
| February, 2027 | $2.44 | $1.9584 | $1.8404 | +79.41% |
| March, 2027 | $2.3355 | $2.3355 | $2.4595 | +71.73% |
| April, 2027 | $1.6477 | $2.1177 | $2.1186 | +21.15% |
| May, 2027 | $1.5998 | $1.6368 | $1.4933 | +17.63% |
| June, 2027 | $2.065 | $1.852 | $1.6696 | +51.84% |
| July, 2027 | $1.7177 | $1.8871 | $1.7041 | +26.30% |
| August, 2027 | $2.3894 | $1.9002 | $2.2535 | +75.69% |
| September, 2027 | $2.7145 | $2.6023 | $2.5445 | +99.59% |
| October, 2027 | $1.5966 | $2.1574 | $2.1275 | +17.40% |
| November, 2027 | $1.9189 | $1.5627 | $1.7088 | +41.09% |
| December, 2027 | $1.4639 | $1.5748 | $1.4548 | +7.64% |
Ernexa Therapeutics Inc Stock (ERNA) Price Forecast for 2028
In 2028, Ernexa Therapeutics Inc (ERNA) is projected to reach an average price of $2.3238, with a high projection of $4.0093 and a low estimate of $0.6382. This indicates an +70.86% rise from the last price of $1.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.7719 | $1.2161 | $1.39 | -43.24% |
| February, 2028 | $0.6382 | $0.6382 | $0.4422 | -53.07% |
| March, 2028 | $0.7658 | $0.6713 | $0.8604 | -43.69% |
| April, 2028 | $3.3119 | $3.472 | $3.245 | +143.53% |
| May, 2028 | $3.6757 | $3.4729 | $3.2857 | +170.27% |
| June, 2028 | $4.2486 | $3.9464 | $3.9886 | +212.40% |
| July, 2028 | $3.7914 | $3.8607 | $4.0093 | +178.78% |
| August, 2028 | $3.035 | $3.136 | $3.5621 | +123.16% |
| September, 2028 | $3.2629 | $3.0757 | $3.0716 | +139.92% |
| October, 2028 | $2.9907 | $3.2293 | $2.9893 | +119.91% |
| November, 2028 | $3.4093 | $3.2028 | $3.0443 | +150.68% |
| December, 2028 | $3.7872 | $3.745 | $3.5672 | +178.47% |
Ernexa Therapeutics Inc Stock (ERNA) Price Forecast for 2029
The 2029 price forecast for Ernexa Therapeutics Inc Stock (ERNA) is $3.5717 on average, with a high prediction of $5.5591 and a low estimate of $1.5843. This represents an +162.63% increase from the previous price of $1.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.1652 | $3.6407 | $3.7493 | +132.74% |
| February, 2029 | $2.6041 | $2.6936 | $2.7214 | +91.48% |
| March, 2029 | $2.6564 | $2.6564 | $2.815 | +95.33% |
| April, 2029 | $2.5693 | $2.6686 | $2.432 | +88.92% |
| May, 2029 | $1.5029 | $1.7229 | $2.41 | +10.51% |
| June, 2029 | $1.5357 | $1.5843 | $1.3436 | +12.92% |
| July, 2029 | $5.06 | $1.7679 | $4.955 | +272.06% |
| August, 2029 | $4.952 | $5.1336 | $4.8968 | +264.12% |
| September, 2029 | $5.4455 | $5.2059 | $5.0155 | +300.41% |
| October, 2029 | $5.3675 | $5.6775 | $5.5591 | +294.67% |
| November, 2029 | $4.6311 | $5.231 | $5.1443 | +240.52% |
| December, 2029 | $4.3225 | $4.5147 | $4.4195 | +217.83% |
Ernexa Therapeutics Inc Stock (ERNA) Price Forecast for 2030
Ernexa Therapeutics Inc Stock (ERNA) is expected to reach an average price of $4.5977 in 2030, with a high forecast of $6.665 and a low forecast of $2.5304. This signifies an +238.07% surge from the last price of $1.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.6066 | $4.583 | $4.4735 | +238.72% |
| February, 2030 | $4.4602 | $4.5902 | $4.3602 | +227.96% |
| March, 2030 | $5.0238 | $4.507 | $4.5538 | +269.39% |
| April, 2030 | $5.0173 | $5.0973 | $4.9323 | +268.92% |
| May, 2030 | $4.3293 | $4.6743 | $4.9541 | +218.33% |
| June, 2030 | $3.9829 | $3.8245 | $3.7777 | +192.86% |
| July, 2030 | $3.6291 | $3.7381 | $3.9213 | +166.85% |
| August, 2030 | $3.1784 | $3.3859 | $3.4313 | +133.71% |
| September, 2030 | $2.392 | $2.592 | $2.7168 | +75.88% |
| October, 2030 | $2.714 | $2.5304 | $2.654 | +99.56% |
| November, 2030 | $6.7121 | $2.6524 | $6.665 | +393.54% |
| December, 2030 | $6.9364 | $6.7943 | $6.5483 | +410.03% |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):